Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 1
2007 1
2008 1
2009 1
2011 1
2012 1
2016 2
2019 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacotherapy for Cocaine Use Disorder-a Systematic Review and Meta-analysis.
Chan B, Kondo K, Freeman M, Ayers C, Montgomery J, Kansagara D. Chan B, et al. J Gen Intern Med. 2019 Dec;34(12):2858-2873. doi: 10.1007/s11606-019-05074-8. Epub 2019 Jun 10. J Gen Intern Med. 2019. PMID: 31183685 Free PMC article.
DISCUSSION: Most of the pharmacotherapies studied were not effective for treating cocaine use disorder. Bupropion, psychostimulants, and topiramate may improve abstinence, and antipsychotics may improve retention. Contingency management and behavioral interventions along w …
DISCUSSION: Most of the pharmacotherapies studied were not effective for treating cocaine use disorder. Bupropion, psychostimulants, …
Combination bupropion SR and varenicline for smoking cessation: a systematic review.
Vogeler T, McClain C, Evoy KE. Vogeler T, et al. Am J Drug Alcohol Abuse. 2016 Mar;42(2):129-39. doi: 10.3109/00952990.2015.1117480. Epub 2016 Jan 25. Am J Drug Alcohol Abuse. 2016. PMID: 26809272 Review.
Current cessation medications include nicotine replacement therapy (NRT), varenicline, and bupropion, while combination therapy primarily entails NRT with either varenicline or bupropion. ...METHODS: PubMed and Clinicaltrials.gov were searched using terms: "varenicl …
Current cessation medications include nicotine replacement therapy (NRT), varenicline, and bupropion, while combination therapy prima …
Clinical outcomes associated with anti-obesity medications in real-world practice: A systematic literature review.
Ahmad NN, Robinson S, Kennedy-Martin T, Poon JL, Kan H. Ahmad NN, et al. Obes Rev. 2021 Nov;22(11):e13326. doi: 10.1111/obr.13326. Epub 2021 Aug 22. Obes Rev. 2021. PMID: 34423889 Free PMC article. Review.
Weight loss (WL) was consistently observed, with 14% to 58.6% of patients achieving 5% WL on orlistat, phentermine/topiramate, naltrexone/bupropion, phentermine, or liraglutide in studies of 3-6 months' duration where this was measured. ...
Weight loss (WL) was consistently observed, with 14% to 58.6% of patients achieving 5% WL on orlistat, phentermine/topiramate, naltrexone/ …
Efficacy and tolerability of switching therapy to vortioxetine versus other antidepressants in patients with major depressive disorder.
Brignone M, Diamand F, Painchault C, Takyar S. Brignone M, et al. Curr Med Res Opin. 2016;32(2):351-66. doi: 10.1185/03007995.2015.1128404. Curr Med Res Opin. 2016. PMID: 26637048 Review.
Three studies contributed to an evidence network for quantitative assessment comparing vortioxetine with agomelatine, sertraline, venlafaxine XR, and bupropion SR. Vortioxetine had a statistically significantly higher remission rate than agomelatine (risk difference …
Three studies contributed to an evidence network for quantitative assessment comparing vortioxetine with agomelatine, sertraline, venlafaxin …
Interventions for smokeless tobacco use cessation.
Ebbert J, Montori VM, Erwin PJ, Stead LF. Ebbert J, et al. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD004306. doi: 10.1002/14651858.CD004306.pub4. Cochrane Database Syst Rev. 2011. PMID: 21328266 Updated. Review.
MAIN RESULTS: Data from one study suggest that varenicline increases ST abstinence rates (Odds Ratio [OR] 1.6, 95% Confidence Interval (CI) 1.08 to 2.36) among Swedish snus users.Two trials of bupropion SR did not detect a benefit of treatment at six months or longe …
MAIN RESULTS: Data from one study suggest that varenicline increases ST abstinence rates (Odds Ratio [OR] 1.6, 95% Confidence Interval (CI) …
Systematic review and meta-analysis of combination therapy for smoking cessation.
Shah SD, Wilken LA, Winkler SR, Lin SJ. Shah SD, et al. J Am Pharm Assoc (2003). 2008 Sep-Oct;48(5):659-65. doi: 10.1331/JAPhA.2008.07063. J Am Pharm Assoc (2003). 2008. PMID: 18826906 Review.
DATA SOURCES: Search terms included in this systematic review were nicotine replacement patch, nicotine replacement therapy, nicotine replacement gum, nicotine replacement inhaler, nicotine replacement nasal spray, nicotine replacement lozenge, bupropion SR (for sus …
DATA SOURCES: Search terms included in this systematic review were nicotine replacement patch, nicotine replacement therapy, nicotine replac …
Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation.
Mahmoudi M, Coleman CI, Sobieraj DM. Mahmoudi M, et al. Int J Clin Pract. 2012 Feb;66(2):171-82. doi: 10.1111/j.1742-1241.2011.02877.x. Int J Clin Pract. 2012. PMID: 22257042 Review.
The purpose of this systematic review was to review the cost-effectiveness of first-line non-nicotine therapies (varenicline and bupropion SR) for smoking cessation, identify differences in the models used and their conclusions of cost-effectiveness, and to determin …
The purpose of this systematic review was to review the cost-effectiveness of first-line non-nicotine therapies (varenicline and bupropio …
Interventions for smokeless tobacco use cessation.
Ebbert JO, Montori V, Vickers KS, Erwin PC, Dale LC, Stead LF. Ebbert JO, et al. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD004306. doi: 10.1002/14651858.CD004306.pub3. Cochrane Database Syst Rev. 2007. PMID: 17943813 Updated. Review.
DATA COLLECTION AND ANALYSIS: Two authors independently extracted data. MAIN RESULTS: Two trials of bupropion SR did not detect a benefit of treatment at six months or longer (Odds Ratio (OR) 0.86, 95% Confidence Interval (CI): 0.47 to 1.57). ...
DATA COLLECTION AND ANALYSIS: Two authors independently extracted data. MAIN RESULTS: Two trials of bupropion SR did not detec …
A tragic triad: coronary artery disease, nicotine addiction, and depression.
Thorndike AN, Rigotti NA. Thorndike AN, et al. Curr Opin Cardiol. 2009 Sep;24(5):447-53. doi: 10.1097/HCO.0b013e32832ed645. Curr Opin Cardiol. 2009. PMID: 19550307 Review.
Stronger nicotine withdrawal symptoms among the depressed smokers contribute to relapse. Secondary analyses suggest that bupropion SR and cognitive behavioral therapy may be effective treatments for smokers with depression and CVD. ...
Stronger nicotine withdrawal symptoms among the depressed smokers contribute to relapse. Secondary analyses suggest that bupropion …
Topiramate for acute affective episodes in bipolar disorder.
Vasudev K, Macritchie K, Geddes J, Watson S, Young A. Vasudev K, et al. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003384. doi: 10.1002/14651858.CD003384.pub2. Cochrane Database Syst Rev. 2006. PMID: 16437453 Review.
MAIN RESULTS: One randomised controlled trial met the inclusion criteria for the review, a comparison between topiramate and bupropion sustained release (SR) in the adjunctive treatment of depressed patients with bipolar disorder. ...From the limited data available, …
MAIN RESULTS: One randomised controlled trial met the inclusion criteria for the review, a comparison between topiramate and bupropion …
12 results